{"disease":{"id":"ovulation-inhibition","name":"ovulation inhibition"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03077555","title":"Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT06396208","title":"\"Quick-starting\" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Chulalongkorn University","has_results":false},{"nct_id":"NCT06396221","title":"\"Quick-starting\" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Chulalongkorn University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}